What are the characteristic clinical findings associated with aldosteronoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aldosteronoma Clinical Features

Aldosteronoma is associated with hypertension, hypokalemia, high aldosterone and low renin levels (option d). 1, 2, 3

Pathophysiology of Aldosteronoma

  • Aldosteronoma (aldosterone-producing adenoma) is characterized by excessive and autonomous production of aldosterone by the adrenal glands, independent of the renin-angiotensin system 1
  • This excessive aldosterone production leads to:
    • Sodium retention and volume expansion 1
    • Suppression of plasma renin activity 1, 3
    • Increased potassium excretion, which can cause hypokalemia if prolonged and severe 1, 3
  • Approximately 50% of patients with primary aldosteronism have unilateral increased aldosterone production, usually due to an aldosterone-producing adenoma 1

Key Clinical Features

  • Hypertension: Patients with aldosteronoma typically present with moderate to marked hypertension that is often resistant to treatment 4, 3
  • Hypokalemia: A classic finding in aldosteronoma, though it may be absent in up to 50% of cases, especially in early stages 4, 1, 5
  • High aldosterone levels: Elevated plasma and/or urinary aldosterone is a hallmark of aldosteronoma 1, 5
  • Low renin levels: Plasma renin activity is suppressed due to the autonomous production of aldosterone 1, 2, 3

Diagnostic Approach

  • The aldosterone-to-renin ratio (ARR) is the most accurate and reliable screening test for aldosteronoma 4, 2
  • A positive ARR is defined as:
    • Ratio >30 (when aldosterone is measured in ng/dL and renin activity in ng/mL/h) 2
    • Plasma aldosterone concentration should be at least 10 ng/dL 2
  • Confirmatory testing is required after a positive screening test to demonstrate autonomous aldosterone production 2
  • Adrenal imaging (CT or MRI) and adrenal venous sampling help differentiate between unilateral adenoma and bilateral hyperplasia 4, 2

Clinical Impact and Complications

  • Aldosteronoma causes greater target organ damage than primary hypertension, including: 4, 3
    • 3.7-fold increase in heart failure
    • 4.2-fold increase in stroke
    • 6.5-fold increase in myocardial infarction
    • 12.1-fold increase in atrial fibrillation
  • Increased left ventricular hypertrophy and diastolic dysfunction 4
  • Increased stiffness of large arteries and widespread tissue fibrosis 4
  • Increased remodeling of resistance vessels and kidney damage 4

Common Pitfalls in Diagnosis

  • Relying solely on hypokalemia as a marker, as it is absent in many cases 2, 5
  • Not screening high-risk patients with resistant hypertension 2
  • Failing to consider medication effects on the aldosterone-renin ratio 2
  • Proceeding with adrenalectomy based on imaging alone without adrenal venous sampling 4, 2

Treatment

  • Unilateral laparoscopic adrenalectomy is the treatment of choice for aldosteronoma 1, 2
  • Surgery improves blood pressure in nearly 100% of patients and achieves complete cure of hypertension in approximately 50% of cases 1, 2
  • Medical therapy with mineralocorticoid receptor antagonists (spironolactone or eplerenone) is an alternative when surgery is not possible 1, 2

References

Guideline

Primary Aldosteronism: Pathophysiology and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Screening for Primary Aldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Relationship between Primary Aldosteronism and Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Differential diagnosis in primary aldosteronism.

The Journal of steroid biochemistry and molecular biology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.